Boston Scientific MedSurg — Cost of products sold increased by 9.5% to $529.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.3%, from $455.00M to $529.00M. Over 3 years (FY 2022 to FY 2025), MedSurg — Cost of products sold shows an upward trend with a 11.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Rising costs relative to sales may indicate manufacturing inefficiencies or inflationary pressure on raw materials.
The direct costs associated with manufacturing and delivering the products sold by the MedSurg segment. This includes ra...
Standard cost of goods sold (COGS) metric for manufacturing-heavy business segments.
bsx_segment_medsurg_cost_of_products_sold| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $350.25M | $350.25M | $350.25M | $350.25M | $367.50M | $367.50M | $367.50M | $367.50M | $381.00M | $401.00M | $412.00M | $455.00M | $435.00M | $470.00M | $483.00M | $529.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +4.9% | +0.0% | +0.0% | +0.0% | +3.7% | +5.2% | +2.7% | +10.4% | -4.4% | +8.0% | +2.8% | +9.5% |
| YoY Change | — | — | — | — | +4.9% | +4.9% | +4.9% | +4.9% | +3.7% | +9.1% | +12.1% | +23.8% | +14.2% | +17.2% | +17.2% | +16.3% |